FDA approvalconf 0.85
CLN-049 — FDA approval
$CGEM · Cullinan Therapeutics, Inc. · Relapsed/Refractory Acute Myeloid Leukemia (AML)
Event date
Date TBD
Sponsor runway
23 mo
$351.9M liquid
Evidence
Comparable historical fda approvals· last 5 years · same event type
100% hit rate (10/10)
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $INCY | zynyz | 2026-05-18 | success |
| $INCY | jakafi xr | 2026-05-01 | success |
| $AXSM | auvelity | 2026-04-30 | success |
| $INCY | zynyz | 2026-03-30 | success |
| $BIIB | spinraza | 2026-03-27 | success |
| $CORT | lifyorli | 2026-03-25 | success |
| $RYTM | imcivree | 2026-03-19 | success |
| $ASND | yuviwel | 2026-02-27 | success |
| $BMRN | palynziq | 2026-02-27 | success |
| $ETON | desmoda | 2026-02-25 | success |
Recent insider activity· ±90 days
1 insider · 0 buys · 2 sells
Exercise10b5-1
2026-05-05Michaelson Jennifer
Chief Scientific Officer
4,000 @ $4.30$17K
Sell10b5-1
2026-05-05Michaelson Jennifer
Chief Scientific Officer
7,800 @ $14.60$114K
Sell10b5-1
2026-05-05Michaelson Jennifer
Chief Scientific Officer
200 @ $15.58$3K